Company: BIVIW
Filing Date: 2025-09-25
Form Type: DEF 14A
Source: 0001520138-25-000287
Chunk: 25

Company: BIOVIE INC.
Filing Date: 2025-09-25
Form: DEF 14A
Chunk 25
---
 — |     |               | — |     |             |     — |     | $        |        — |     |            | —        |     |              | 100 |     | $          |   925 |     |               | — |     |               | — |
|                                                      |     | 06/07/23   |     |             |   180 |     |               | — |     |             |   120 |     | $        |   578.00 |     |            | 06/07/33 |     |              |   — |     |            |     — |     |               | — |     |               | — |
|                                                      |     | 06/24/24   |     |             | 1,040 |     |               | — |     |             |   520 |     | $        |    47.40 |     |            | 06/24/34 |     |              |   — |     |            |     — |     |               | — |     |               | — |
|                                                      |     | 12/20/24   |     |             |   514 |     |               | — |     |             | 1,028 |     | $        |    19.00 |     |            | 12/20/34 |     |              |   — |     |            |     — |     |               | — |     |               | — |

| -16- |

Our NEOs held stock options to purchase a total of 17,415 shares of common
stock as of June 30, 2025, with an aggregate grant date fair value of approximately $5.6 million, the last of which vests in 2027. Stock
options granted prior to August 20, 2021, vested on the grant date; the stock options granted on August 20, 2021 vested 20% on the grant
date, with the remaining stock options vesting in five equal annual installments beginning on the first grant date anniversary; the stock
options granted on June 7, 2023, vested 25% on the grant date, with the remaining stock options vesting in four equal annual installments
beginning on the first grant date anniversary; and the stock options and stock awards in the form RSUs granted to the CEO on June 21,
2022 and June 29, 2023 vests in three